|
Leading Article
Money-back
guarantees for new drugs
News & Features
News
(including R&D and news in brief)
New pharmacy services: What's on offer [more]
Comment
Broad Spectrum: Pharmacy technician development —
frustrations and opportunities...[more]
Letters
to the Editor
Original
papers
From
hospital admission to discharge: an exploratory study to evaluate seamless
care
»(PDF*,
65K)
Meetings
Primary
Care and Community Pharmacy Network: Meeting the challenge of change [more]
Neonatal
and Paediatric Pharmacy Group [more]
UK Psychiatric Pharmacy
Group [more]
Onlooker
The Society
News
MEP:
November amendments
From
the Branches
Obituaries
and tributes
Offical
notices
Notice-board
Branch
meetings
Future
events
Health promotions
Conferences
and more
Products
|
Front Cover Picture
This week's front cover picture (Christopher Icha) is intended to
represent how pharmacists can consider introducing a variety of new quality
services for patients. Our news
feature this week reports on how pharmacists can contribute to modernising
the NHS by providing new services and improving pharmacy premises.
Fluoroquinolones
Ciprofloxacin and other fluoroquinolones could be associated with severe
adverse events.
Beta-interferon
A "money-back" deal might be struck between manufacturers of beta-interferon
and the Department of Health to enable multiple
sclerosis patients to try a course of treatment.
Leading article.
Jury service
Most pharmacists can expect to lose their automatic
exemption from calls to serve on juries.
Seamless care
Research published this week shows that a pharmacist's intervention improves
patients' ability to recall their medication regimen and reduces the number
of drug errors.
Recalls
GlaxoSmithKline has recalled a batch of Seretide
50 Evohalers, distributed in the livery of Allen & Hanburys (p641).
|
